Achieve Life Sciences Inc (ACHV)

$5.42

+0.21

(+4.03%)▲

Live

Insights on Achieve Life Sciences Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 72.6% return, outperforming this stock by 95.3%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 235.1% return, outperforming this stock by 274.9%

Performance

  • $5.15
    $5.57
    $5.42
    downward going graph

    4.98%

    Downside

    Day's Volatility :7.46%

    Upside

    2.61%

    downward going graph
  • $3.03
    $6.87
    $5.42
    downward going graph

    44.1%

    Downside

    52 Weeks Volatility :55.9%

    Upside

    21.11%

    downward going graph

Returns

PeriodAchieve Life Sciences IncIndex (Russel 2000)
3 Months
17.87%
0.0%
6 Months
-9.55%
0.0%
1 Year
-19.22%
0.0%
3 Years
-39.77%
-22.6%

Highlights

Market Capitalization
183.0M
Book Value
$1.44
Earnings Per Share (EPS)
-1.26
PEG Ratio
0.0
Wall Street Target Price
18.88
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-33.93%
Return On Equity TTM
-109.49%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-24.4M
Diluted Eps TTM
-1.26
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.07
EPS Estimate Next Year
-0.93
EPS Estimate Current Quarter
-0.24
EPS Estimate Next Quarter
-0.23

Analyst Recommendation

Buy
    92%Buy
    7%Hold
    0
    0%Sell
Based on 13 Wall street analysts offering stock ratings for Achieve Life Sciences Inc(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
11
11
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 248.34%

Current $5.42
Target $18.88

Technicals Summary

Sell

Neutral

Buy

Achieve Life Sciences Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Achieve Life Sciences Inc
Achieve Life Sciences Inc
14.0%
-9.55%
-19.22%
-39.77%
-93.25%
Moderna, Inc.
Moderna, Inc.
21.03%
85.08%
14.68%
-28.27%
659.22%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
3.22%
20.18%
31.88%
93.3%
227.58%
Novo Nordisk A/s
Novo Nordisk A/s
8.85%
34.38%
71.83%
235.07%
463.44%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
16.81%
34.1%
40.6%
123.97%
174.53%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Achieve Life Sciences Inc
Achieve Life Sciences Inc
NA
NA
0.0
-1.07
-1.09
-0.34
NA
1.44
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.14
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
28.89
28.89
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
46.97
46.97
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
29.59
29.59
0.53
17.08
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Achieve Life Sciences Inc
Achieve Life Sciences Inc
Buy
$183.0M
-93.25%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$54.6B
659.22%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.0B
227.58%
28.89
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$602.6B
463.44%
46.97
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$117.5B
174.53%
29.59
39.46%

Institutional Holdings

  • Sofinnova Ventures

    4.43%

  • Vanguard Group Inc

    2.77%

  • Nantahala Capital Management, LLC

    1.91%

  • Alyeska Investment Group, L.P.

    1.38%

  • Shay Capital LLC

    1.31%

  • Long Focus Capital Management, LLC

    0.72%

Company Information

achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.

Organization
Achieve Life Sciences Inc
Employees
22
CEO
Dr. Richard A. B. Stewart
Industry
Health Technology

Discover More

FAQs